Found 0 matching trials
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS PHASE2 The objective of this Phase II, open-label, multicenter, non-randomised con...
Show More Location
Multiple Locations
Learn More & Join Trial
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact NA IgE-associated allergies are consistently on the rise forming an enormous w...
Show More Location
Medical University of Vienna
Learn More & Join Trial
EUS-guided Fine Needle Aspiration (FNA) With and Without the Use of a Stylet NA The purpose of this study is to determine that there is no difference in fi...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
National Registry of Rare Kidney Diseases N/A The goal of this National Registry is to is to collect information from pat...
Show More Learn More & Join Trial
A Study to Assess Multidomain Endpoints of an ECG Patch N/A This study aims to evaluate the utility of a wearable heart monitoring patc...
Show More Learn More & Join Trial
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) N/A The goal of this observational study is to comprehensively profile six immu...
Show More Location
Radboud University Medical Center
Learn More & Join Trial
DEliriuM in STroke: the Link Between Stroke, Delirium and Long-term Cognitive Impairment N/A Primary objective of this study:
determine whether PSD is a risk factor fo...
Show More Location
Universitair Ziekenhuis Brussel
Learn More & Join Trial
Does Improved Ability to Achieve Single Leg Stance Lead to a More Efficient Gait Pattern in Adults With Acquired Brain Injury? NA The purpose of the study is to see if a person can stand better on their we...
Show More Location
Trafford General Hospital
Learn More & Join Trial
Spreading Depolarizations in Traumatic Brain Injury N/A This research aims to extend the application of spreading depolarization mo...
Show More Location
University of California San Francisco
Learn More & Join Trial
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1 In this phase 1 open label study for patients with type I punctate palmopla...
Show More Location
Soroka Medical Center
Learn More & Join Trial